Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enoyl-CoA hydratase is a mitochondrial enzyme that catalyzes the reversible hydration of the double bond in enoyl-CoA thioesters during fatty acid β-oxidation, producing 3-hydroxyacyl-CoA. The human short-chain isoform (ECHS1) is vital for the degradation of short- and medium-chain fatty acids and operates at near-diffusion controlled rates. Structurally, it forms a hexamer and employs two catalytic glutamate residues to mediate a syn-addition of water across the substrate double bond. Genetic defects in ECHS1 cause severe mitochondrial disorders, highlighting its critical role in energy homeostasis and human health. Enoyl-CoA hydratase belongs to the crotonase superfamily and is also involved in branched-chain amino acid catabolism in some contexts. There are research-grade inhibitors, but clinically-approved drugs targeting this enzyme are not yet established.
Competitive inhibition (e.g., substrate analogs bind the active site to block activity). Covalent adduct formation with active site residues leading to irreversible enzyme inactivation. Modulation of catalytic glutamate residues (Glu144, Glu164) which are essential for hydration reaction.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enoyl-CoA hydratase (ECH (also ECHS1 for the human short-chain isoform)).